Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
20.77
-1.50 (-6.74%)
Nov 20, 2024, 4:00 PM EST - Market closed
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $614.73 million as of November 21, 2024. Its market cap has increased by 249.31% in one year.
Market Cap
614.73M
Enterprise Value
333.92M
1-Year Change
249.31%
Ranking
Category
Stock Price
$20.77
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $614.73M, an increase of 277.15%. That is a compound annual growth rate of 204.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 614.73M | 298.90% |
| Dec 29, 2023 | 154.10M | -5.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oculis Holding AG | 625.40M |
| AnaptysBio | 618.01M |
| OrthoPediatrics | 617.51M |
| ORIC Pharmaceuticals | 616.76M |
| Tourmaline Bio | 615.42M |
| Standard BioTools | 599.34M |
| Stoke Therapeutics | 599.06M |
| Phathom Pharmaceuticals | 596.93M |